Dimethylaminopropionitrile
|
CAS
1738-25-6
|
(CH3)2NCH2CH2CN
|
RTECS
UG1575000
|
Synonyms & Trade Names
3-(Dimethylamino)propionitrile; N,N-Dimethylamino-3-propionitrile [Note: A component (95%) of NIAX® Catalyst ESN, along with bis(2-(dimethylamino)ethyl) ether (5%).]
|
DOT ID & Guide
|
Exposure
Limits
|
NIOSH REL: See Appendix C (NIAX® Catalyst ESN)
|
|
OSHA PEL: See Appendix C (NIAX® Catalyst ESN)
|
IDLH
N.D.
See: IDLH INDEX
|
Conversion
|
Physical Description
Colorless liquid.
|
MW: 98.2
|
BP: 342°F
|
FRZ: -48°F
|
Sol: Miscible
|
VP(135°F): 10 mmHg
|
IP: ?
|
|
Sp.Gr(86°F): 0.86
|
Fl.P: 147°F
|
UEL: ?
|
LEL: ?
|
|
|
Class IIIA Combustible Liquid: Fl.P. at or above 140°F and below 200°F.
|
Incompatibilities & Reactivities
Oxidizers [Note: Emits toxic oxides of nitrogen and cyanide fumes when heated to decomposition.]
|
Measurement Methods
None available
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet or contaminated
Change: No recommendation
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Water flush immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Irritation eyes, skin; urinary disturbance; neurological disorders; pins & needles in hands & feet; muscle weakness, lassitude (weakness, exhaustion), nausea, vomiting; decreased nerve conduction in lower legs
|
Target Organs
Eyes, skin, central nervous system, urinary tract
|
